Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,821,304
-
Total 13F shares
-
32,469,409
-
Share change
-
+201,921
-
Total reported value
-
$79,220,415
-
Put/Call ratio
-
2.4%
-
Price per share
-
$2.44
-
Number of holders
-
70
-
Value change
-
-$5,272,473
-
Number of buys
-
45
-
Number of sells
-
25
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q2 2024
As of 30 Jun 2024,
Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,469,409 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., Rubric Capital Management LP, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.